STAT+: Instead of credible data, PDS Biotech delivers ‘results might get better, later’ promises
Tumor response rate is a common way to assess the efficacy of a cancer drug….
Category: cancer
STAT+: Moving past regulatory obstacles, Protagonist Therapeutics looks to pivotal trial for its rare blood disorder therapy
FRANKFURT, Germany — Protagonist Therapeutics has run into some speed bumps as it’s developed its…
STAT+: Pharmalittle: U.S. Chamber sues over Medicare price negotiations; FDA seeks new supplier for scarce cancer drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Kura Oncology highlights leukemia remission data as it enrolls larger trial
FRANKFURT — A genetically targeted cancer drug from Kura Oncology has helped put more patients’…
STAT+: ASCO showcased the payoff for new cancer medicines: longer lives
CHICAGO — Well, that’s a wrap. The biggest meeting in cancer research — and, really,…
Opinion: Want to help with medical breakthroughs? Donate some extra cells to a biobank
Right now, it’s possible that cells from my body are growing in a lab somewhere…
STAT+: Buoyed by cancer advances, new ASCO president also stresses honest prognosis
CHICAGO — As a busy weekend at the American Society of Clinical Oncology annual meeting…
STAT+: FDA will allow troubled chemotherapy maker to resume distribution of cancer drugs in short supply
After finding a “cascade of failures” at a manufacturing plant run by a key chemotherapy…
STAT+: Novocure’s electric fields device prolongs survival in lung cancer, but doubts remain
CHICAGO — A medical device made by Novocure that creates electric fields in the lungs…
STAT+: The woman behind AstraZeneca’s cancer winning streak
CHICAGO — It was the kind of moment scientists who develop new medicines wait their…
STAT+: FDA oncology head wants advisory panels to keep voting on new drugs
CHICAGO — As commissioner of the Food and Drug Administration, Robert Califf has made clear…
STAT+: Gilead’s CAR-T therapy prolongs survival in key blood cancer trial
CHICAGO — Yescarta, the CAR-T therapy made by the Kite unit of Gilead Sciences, prolonged…
‘We arguably saved their lives’: Newborn DNA-sequencing reveals elevated cancer risks for parents
Ten years ago, clinicians in a handful of hospitals around the United States began sequencing…
STAT+: Keytruda’s benefits, a breast cancer win, the ‘dom-zim doublet’: Weekend wrap-up from ASCO
CHICAGO — The annual meeting of the American Society of Clinical Oncology is back in…
STAT+: ‘Extraordinary’ survival data for lung cancer patients is seen as boost for AstraZeneca drug
CHICAGO – Giving the AstraZeneca drug Tagrisso to patients with non-small cell lung cancer who…
STAT+: Targeted drug greatly slows progression of a brain cancer
CHICAGO – An experimental drug dramatically slowed the growth of glioma, a type of brain…
STAT+: Immunogen drug prolongs survival of women with advanced ovarian cancer
CHICAGO — An antibody that delivers chemotherapy directly to tumor cells extended the lives of…
Cross-border ‘twinning programs’ may reduce survival disparities for childhood leukemia
A few miles can mean a life or death difference to children with cancer, if…
After outcry, UnitedHealthcare softens prior authorization policy for colonoscopies
After weeks of protest from physician organizations and patients, UnitedHealthcare has put a controversial new…
Listen: Fake medical devices, real cancer drugs, & curious Ozempic effects
Why are fake medical devices more lucrative than real ones? Is Ozempic a neurological treatment?…
STAT+: Tempus launches an AI ‘assistant’ for thousands of oncologists
Tempus, a company that combines DNA sequencing for cancer with artificial intelligence, said Thursday that…
STAT+: Debt ceiling deal could mean cancer, disease research cuts, advocates warn
WASHINGTON — Researchers and health care advocates are warning that the debt ceiling deal would…
Opinion: Newly diagnosed cancer patients need help navigating the system
“Hey, I’m sorry to bother you, but I could really use your advice on something.”…
Opinion: Listen: Ezekiel Emanuel explains why cancer patients shouldn’t pay out-of-pocket costs
The high cost of cancer treatment in the U.S. is literally killing people. “Over a…
Medical Nutrition Therapy Focuses on Eating to Improve Your Health
Does this scenario sound familiar? You see your doctor and discuss a medical condition you…
Don’t Take Psoriasis Lightly: It May Affect More Than Your Skin
Having a mild case of psoriasis may be more of a bothersome annoyance than a…
Be Alert for Signs of Gynecological Cancer
For all of types of cancer, an early diagnosis means earlier treatment and a higher…
Ask Dr. Etingin: Types of anemia; Causes of cirrhosis; Type 1 and type 2 diabetes
What’s the difference between pernicious anemia and iron deficiency anemia? Anemia is a condition in…
STAT+: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
In a study reported Thursday, a medicine from Bristol Myers Squibb nearly doubled the treatment…
STAT+: Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clinical trials advance
LONDON — The promise of immunotherapies to treat cancer has yet to reach brain tumors….
Medication Management
Q: I have several pills to take twice a day to manage my chronic conditions….
Are You Losing Muscle?
We all lose muscle as we age. Roger A. Fielding, PhD, a professor of biochemical…
Opinion: Cancer patients shouldn’t be responsible for out-of-pocket costs
In 2023, just under 2 million Americans will be diagnosed with cancer. Many will endure…
STAT+: A new startup looks to turn the workhorse of gene therapy against cancer
In 1980, Life and Time magazines introduced America to a new cancer wonder drug: interferon,…
Opinion: New draft recommendations for mammograms take a one-size-fits-all approach
On May 9, the United States Preventive Services Task Force (USPSTF) released updated draft recommendations…
Opinion: Starting breast cancer screening at 40 saved my life
In 2015, the year I turned 40, the American Cancer Society updated its guidelines for…
STAT+: Boundless Bio tests a cancer drug targeting once-mysterious DNA loops
SAN DIEGO — Peering through a microscope more than a half century ago, researchers made…
Biden nominates Monica Bertagnolli to head NIH
WASHINGTON — President Biden on Monday officially announced that he would nominate National Cancer Institute…
‘Stunning’ change to United’s colonoscopy coverage roils physicians and patients
When gastroenterologists learned in March that UnitedHealthcare plans to barricade many colonoscopies behind a controversial…
From fusion to retooling cancer trials, Eric Lander wants his new group to ‘go after big problems’
Throughout his storied career, Eric Lander has led science projects in just about every setting…
An ultrasound device may unlock brain cancer treatment, early study shows
Brain cancer patients are left with few options when tumor cells spread, as most potent…
STAT+: Brigham creates institute focused on immunology with record $100 million gift
Brigham and Women’s Hospital will launch a new institute focused on immunology and inflammation, thanks…
STAT+: In small study, weight loss drug boosts immune cells that help fight cancer
Drugs like Ozempic and Wegovy have become immensely popular for their ability to help people…
Breast cancer screening should begin at 40, not 50, federal health panel recommends
The United States Preventive Services Task Force on Tuesday created new guidelines recommending all women…
STAT+: NIH grant recipients often fail to disclose agency support in patent applications
The National Institutes of Health may be the largest public funder of biomedical research in…
‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer
New technologies are making it possible to detect cancer earlier than ever — but the…
STAT+: Senator pushes NIH for ‘formal’ review of Covid response
WASHINGTON — Republicans continued to press top health officials on the coronavirus response during a…
STAT+: CAR-T research is flourishing but is hampered by outdated precautions, experts say
Twenty years ago, CAR-T cell therapy was not quite “believed in,” said Michel Sadelain, director…
An MRI helmet out of ‘Back to the Future’ wins STAT Summit research pick
The pitches are as ambitious as they are exciting: a gel to rub onto your…
After early-stage breast cancer, interrupting endocrine therapy to become pregnant didn’t raise risk of recurrence
Women who’ve been treated for hormone-sensitive breast cancer often face five to 10 years of…